All lobbying filings

Summit Health Care Consulting

Summit Health Care Consulting filed a Q2 termination report for American College of Osteopathic Internists on July 21, 2026, reporting $21,600 in lobbying income.

Lobbying for American College of Osteopathic Internists · Professional medical society for osteopathic internists.

As filed: SUMMIT HEALTH CARE CONSULTING for AMERICAN COLLEGE OF OSTEOPATHIC INTERNISTS.

All filings by Summit Health Care Consulting · Everything American College of Osteopathic Internists has reported

Filing · LD-2 quarterly report Q2 termination

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 21, 2026

Income

$21,600

What the client paid this registrant for the period.

Client based in

Virginia

Representation ended

Jun 30, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Support the Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026. Applies prior auth reforms to Part D, CHIP, Medicaid. Not introduced in the 2nd Quarter Support the Fair Access in Residency (FAIR) Act (H.R. 2314 and S. 2715) to require equal recognition of the Comprehensive Osteopathic Medical Licensing Exam (COMLEX) Support the Improving Seniors' Timely Access to Care Act (H.R. 3514 / S. 1816)

Health Issues

Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192), which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.

Bills named in this filing 5

H.R. 2314
FAIR Act
S. 2715
FAIR Act of 2025
H.R. 3514
Improving Seniors’ Timely Access to Care Act of 2025
S. 1816
Improving Seniors’ Timely Access to Care Act of 2025
H.R. 9192
Prior Authorization Reform for Autoimmune and Blood Disorders Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.